UNSPSC 85812514: Introduction of monoclonal antibody into mouth and pharynx, external approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into mouth and pharynx, external approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0DX0M

UNSPSC 85812514 Introduction of monoclonal antibody into mouth and pharynx, external approach is a Commodity code that shows limited recent alignment with state and local procurement activity. The code's medical taxonomy frames a specific clinical procedure—topical monoclonal antibody administration—yet recent state and local opportunities tagged under or near this code span a much broader range of health services, from telehealth and occupational health to cancer screening, wellness programs, and opioid treatment, suggesting the code is either underutilized for its nominal scope or misapplied to catchall health service procurements. The issuing bodies represent a wide cross-section of state and local healthcare purchasers: health plans (Inland Empire Health Plan, California), counties (DeKalb, Forsyth, Santa Clara, San Mateo), state health authorities (Nevada Health Authority), municipalities (City of Phoenix, City of Ocala), and specialized districts. No single buyer emerges as a repeat user of this specific code, and the geographic spread spans California, Georgia, Nevada, Florida, Colorado, Illinois, Texas, and multiple other states.

The most recent representative opportunity is Inland Empire Health Plan's RFI for Virtual Urgent Care Services (due October 31, 2026), which seeks 24/7/365 telehealth evaluation and medication management—plainly distant from the code's monoclonal antibody focus. Other opportunities include Nevada Health Authority's PACE program RFP (due December 10, 2026) for comprehensive senior care including physician services and therapies, DeKalb County's Medical Services RFP (due November 12, 2026) with no scope detail disclosed, and San Mateo Medical Center's Cancer Registry Services RFP (due October 12, 2026). The code shows no active procurement targeting monoclonal antibody delivery, topical pharmaceutical administration, or related immunotherapy services. State and local governments appear to be using this Commodity code as a generic bin for health services procurement rather than procuring the specific clinical service the code names. The code carries limited decision relevance for firms focused on monoclonal antibody or biopharmaceutical delivery unless their service lines extend broadly into primary care, occupational health, or behavioral health administration.